Synthetic opioids

Sabrina Strong, an attorney for Johnson & Johnson and its subsidiaries, answers a question during a news conference following the announcement of the decision in in the Opioid Lawsuit in Norman, Okla., Monday, Aug. 26, 2019. (AP Photo/Sue Ogrocki)
August 26, 2019 - 10:00 pm
NORMAN, Okla. (AP) — The Latest on Oklahoma's opioids case against Johnson & Johnson (all times local): 5:10 p.m. An Oklahoma judge has found Johnson & Johnson and its subsidiaries helped fuel the state's opioid drug crisis, ordering the consumer products giant to pay $572 million to help...
Read More
FILE - In this Aug. 19, 2019, file photo traders Gregory Rowe, left, and Michael Milano work on the floor of the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EDT on Friday, Aug. 23. (AP Photo/Richard Drew, File)
Associated Press
August 23, 2019 - 12:29 pm
Stocks fell sharply on Wall Street Friday after President Donald Trump called on U.S. companies to consider alternatives to doing business in China. He also said he would respond to Beijing's latest tariff increase. The Dow Jones Industrial Average sank more than 400 points after the president made...
Read More
August 16, 2019 - 3:47 pm
New York officials are demanding that banks and other companies with connections to the family that owns OxyContin maker Purdue Pharma hand over financial records as the state tries to trace where money from opioid sales ended up. The state attorney general's office began issuing subpoenas this...
Read More
August 06, 2019 - 5:39 pm
WASHINGTON (AP) — The government is clarifying a policy change that will limit the prescribing of opioid painkillers to federal workers. The Labor Department issued a statement Tuesday saying the limitations will apply to employees injured on the job and covered under the government's workers'...
Read More
Protesters, including Carol Lorento, center, gather outside a courthouse on Friday, Aug. 2, 2019, in Boston, where a judge was to hear arguments in Massachusetts' lawsuit against Purdue Pharma over its role in the national drug epidemic. Organizers said they wanted to continue to put pressure on the Connecticut pharmaceutical company and the Sackler family that owns it. (AP Photo/Charles Krupa)
August 02, 2019 - 1:45 pm
BOSTON (AP) — They came bearing oversized images of the sons and daughters they lost to drug overdoses and signs demanding justice from the pharmaceutical company they hold most responsible. The parents and their supporters rallied outside a Boston courthouse Friday as a judge heard arguments in...
Read More
FILE - This Tuesday, May 8, 2007, file photo shows the Purdue Pharma logo at its offices in Stamford, Conn. Arizona's attorney general is asking the U.S. Supreme Court to force the Sackler family, which owns OxyContin-maker Purdue Pharma, to return billions of dollars they took out of the company. The court filing on Wednesday, July 31, 2019, marks the first time the high court has been asked to weigh in directly on the nation's opioid crisis. (AP Photo/Douglas Healey, File)
July 31, 2019 - 7:09 pm
PHOENIX (AP) — Arizona's attorney general on Wednesday asked the U.S. Supreme Court to force the Sackler family, which owns OxyContin-maker Purdue Pharma, to return billions of dollars they took out of the company. The court filing marks the first time the high court has been asked to weigh in...
Read More
FILE - This Sept. 17, 2015, file photo shows a sign barring smoking at the state Capitol in Oklahoma City. The signs were paid for by the Oklahoma Health Department, which works in conjunction with the Tobacco Settlement Endowment Trust to reduce smoking. Fifteen years after its creation, programs launched by the Tobacco Settlement Endowment Trust have dramatically reduced tobacco use among Oklahomans. (AP Photo/Sue Ogrocki, File)
July 29, 2019 - 11:54 am
The roughly 2,000 state and local governments suing the drug industry over the deadly opioid crisis have yet to see any verdicts or reach any big national settlements but are already tussling with each other over how to divide any money they collect. The reason: Some of them want to avoid what...
Read More
FILE - This April 30, 2007, file photo, shows the headquarters of Cardinal Health in Dublin, Ohio. An executive at Cardinal Health, one of the nation’s largest drug distribution companies, said in a legal proceeding that the business has no obligation to the public when it comes to shipping prescription opioid painkillers. That’s one of the disclosures in thousands of pages of court documents made public July 23, 2019, in lawsuits over the opioid crisis. (AP Photo/Kiichiro Sato, File)
July 24, 2019 - 2:56 pm
WASHINGTON (AP) — In 2012, as the death toll from the nation's opioid crisis mounted, drug companies shipped out enough of the powerful and addictive painkillers for every man, woman and child in the U.S. to have nearly a 20-day supply. In some counties, mostly in Appalachia, it was well over 100...
Read More
FILE - In this Aug. 17, 2018 file photo, Christine Gagnon, of Southington, Conn., holds a sign during a protest with others who have lost loved ones to OxyContin and opioid overdoses, outside the Purdue Pharma headquarters in Stamford, Conn. Gagnon lost her son Michael 13 months earlier. Nearly ten years ago, the blockbuster painkiller OxyContin was reformulated to discourage abuse by snorting and injecting, but it's unclear whether the harder-to-abuse format has decreased cases of addiction, overdose and death. (AP Photo/Jessica Hill, File)
July 22, 2019 - 12:32 pm
WASHINGTON (AP) — Dr. Raeford Brown was uniquely positioned to help the U.S. government answer a critical question: Is a new version of the painkiller OxyContin helping fight the national opioid epidemic? An expert in pain treatment at the University of Kentucky, Brown led a panel of outside...
Read More
FILE - In this Aug. 17, 2018 file photo, Christine Gagnon, of Southington, Conn., holds a sign during a protest with others who have lost loved ones to OxyContin and opioid overdoses, outside the Purdue Pharma headquarters in Stamford, Conn. Gagnon lost her son Michael 13 months earlier. Nearly ten years ago, the blockbuster painkiller OxyContin was reformulated to discourage abuse by snorting and injecting, but it's unclear whether the harder-to-abuse format has decreased cases of addiction, overdose and death. (AP Photo/Jessica Hill, File)
July 22, 2019 - 10:37 am
WASHINGTON (AP) — Nearly a decade ago, the maker of OxyContin responded to a growing wave of opioid abuse by making the painkiller harder to snort and inject. But has that reformulation translated into fewer drug overdoses and deaths? It's a question that experts like Dr. Raeford Brown of the...
Read More

Pages